Search

everythinglearnresearchcommunity

for

Search:↓

Microneedles are effective for painless drug delivery and promoting wound healing and tissue regeneration.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

New CRISPR/Cas9 variants and nanotechnology-based delivery methods are improving cancer treatment, but choosing the best variant and overcoming certain limitations remain challenges.

New pharmaceutical biomaterials, especially nanomaterials, show promise for improving cancer treatment and disease diagnosis.

The new ddPCR method reliably detects unwanted viruses in CAR-T cell products, ensuring their safety for patients.

Self-amplifying RNA could be a better option for protein replacement therapy with lower doses and lasting effects, but delivering it into cells is still challenging.

New Australian advertising rules improved stem cell marketing practices but further regulation is needed for consumer safety.

Patients in Australia underwent costly, unproven stem cell treatments due to weak regulations and aggressive marketing.

CRISPR/Cas9 has improved precision and control but still faces clinical challenges.

Genetically modified stem cells from human hair follicles can lower blood sugar and increase survival in diabetic mice.

Modified KGF mRNA helps skin cells grow and move faster, which may improve wound healing.

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.

Human hair keratins K85 and K35 create unique filament patterns important for early hair formation.

Tiny fat-derived particles can help repair soft tissues by changing immune cell types.

Surface-modified nanostructured lipid carriers can improve hair growth treatments.

Overexpressing Tβ4 in cashmere goats improves hair fiber traits and increases cashmere yield.

Chitosan hydrogels are promising for repairing blood vessels but need improvements in strength and compatibility.

Herbal formula shows promise for hair loss treatment.

The document emphasizes the importance of ongoing research and ethical considerations in genome editing and cellular reprogramming.

Increasing Rps14 helps grow more inner ear cells and repair hearing cells in baby mice.

Plant-derived extracellular vesicles show promise for treating diseases like cancer and inflammation.

The Wnt/β-catenin pathway is important for tissue development and has potential in regenerative medicine, but requires more research for therapeutic use.

Biomimetic scaffolds are better than traditional methods for growing cells and could help regenerate various tissues.

Lotion with fucoidan from brown seaweed improved skin and reduced allergy symptoms in mice with dermatitis.

People with alopecia have shorter hair follicles and more c-kit, a stem cell factor receptor, which could predict how the condition progresses.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

miRNA-based therapies show promise for treating skin diseases, including hair loss, in animals.

More precise, personalized therapies are needed for autoimmune diseases.

Hair follicle stem cells need all reprogramming factors to become pluripotent.

Further research is needed to improve hair regeneration using stem cells and nanomaterials.